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Putative risk facws for the development of p&menopausal osteopomsis (PMO) with vertebral frac- 
tu:es were examined in a retrospective study cmf 663 postmenopausal white females aged 45-Z years 
(266women with non-traumatic vertebral compresrion fractures (VF+), 134 non-fractured women from 
a general medicine clinic (controls) and 263 non-fractured women who were evaluated when they DW 
sented specifically for osteoporosis scwzning (VF-)). The VF+ women differed from control won&, in 
several rcspene. The VF+ group repwted a higher prevalence of a positive family history of osteopxo- 
sis, and a higher prevalence of a history of medical or surgical conditions known to be independently as- 
sociated with metabolicbone disease, had fewer children. were smaller (weight, height) and were slight- 
ly older. The two groups. VFt nnd controls, did not differ with respect gcigaret& smoking, al&ho1 
consumptian. exe&e habits, menstrual or menopausal history, dietary intake of milk and cheese or in 
amauntmkingcalcium supplementsduringpre8nancy. 
The VF+ group also differed in certain respects from the VP- group. The W+ group wcrc smaller 
(weight, height) and were older. The VF+ gmup had lower conical bone mass (measured by rimle pho- 
ton absorptiometry of the non.dominant forearm) than either the contml or VF- groups. The latter two 
groups did not differ from each other with .espect to this measurement. 
These markers demonstrated limited sensitivity and speciticily as estimated fmm 8 confirmatory data 
set, particularly for the historical and antbmpometric variables. We cmlclude that an assessment of the 
risk of developing PM0 with vertebral fracwes cannot he based an the putative risk factors as measured 
in our study, but must be based an measurement of bone mass. 
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IntrotJuctlen 
The magnitude of the community health problem posed by postmenopausal os- 
teoporosis (PMO) has been amply documented in the medical and lay literature 
over the past several years. Since a proven effective therapy for osteoporosis has 
not yet been established, it seems prudent to seek out and implement an effective 
prophylactic program to minimize the prevalence of this disease in the community. 
Such a program, early (within 5-7 years of the menopause) and prolonged (mini- 
mum 5-10 years) administration of estrogen, has been clearly and repeatedly dem- 
onstrated to retard the rate of postmenopausal bone loss [1,2] and significantly re- 
duce the incidence of osteoporotic fractures of the forearm [3], spine [4,5] and hips 
[3,6-81. There is a reluctance on the part of physicians and the general public to 
implement this prophylactic program on a widespread basis without making some 
attempt to identify those women wbo are at greatest risk for the development of os- 
teoporosis and therefore most likely to receive greatest benellt from prophylaxis. 
There is usually a lag time of lo-15 years between the last menstrual period and 
the development of the first osteoporotlc vertebral fracture. To gather data on wo- 
men age 50 and follow them until age 65 in order to prospectively test our ability to 
accurately predict who will or will not develop osteoporosis with fracture would be 
a tremendous undertaking, and is unlikely to be performed in one institution. We 
therefore undertook a retrospective study in an attempt to document those pre- 
sumed risk factors that were more prevalent in women with osteoporotic vertebral 
Fractures when compared to a non-Fractured population. 
Metbodsand Materials 
Subjects 
All participants were white females aged 45-75 and who were at least one year 
postmenopausal at the time of evaluation. Three groups of subjects were analysed. 
Screened sltbjects 
These two groups consisted of women meeting the above criteria and presenting for 
possible inclusion into a clinical trial studying the efficacy of sodium fluoride on OS- 
teopnrosis. Subjects were solicited by media announcements of the trial and by no- 
tifying referring physicians of the trial. All women were physician or self-referred 
to tbe Bone and Mineral Division of Henry Ford Hospital, because osteoporosis 
was suspected or there was concern about the risk of developing osteoporosis. All 
patients were interviewed and examined by a phySiCian and/or research nurse. All 
patients were classified into the following two groups. 
Vertebral fracture group (VF+) (n = X6] 
The VF+ group included women with definite postmenopausal osteoporosis with 
one or more vertebral compression fractures that had occurred in the absence of 
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trauma or in response to only trivial trauma. Radiographic documentation ofverte- 
bra1 fractures was obtained for each subject using criteria we have previously re- 
ported [9]. 
Nonwrtebralfracturee group (VF-) (n = 263) 
The VF- group included women without evidence of one or more vertebral com- 
pression fractures that had occurred in the absence of trauma or in response to only 
trivial trauma. The absence of fracture was confirmed by radiographic documenta- 
tion. 
Clinic subjects 
Contmlgroup (C) (n = 134) 
The control group included consecutive patients who attended the general internal 
medicine clinics at two satellite facilities of Henry Ford Hospital. They had never 
been physician or self-referred to the Bone and Mineral Division and all denied 
ever having sought medical attention or advice about osteoporosis. Seventy-seven 
of these women were interviewed by telephone by a research nurse within one week 
of their attendance at the general medical clinic. The remaining 57 women were in- 
terviewed by telephone the day prior to their appointment at the clinic. Weight and 
height measurements were abstracted from the patient’s medical record for that 
clinic visit. Radiographic documentation of the presence or absence of vertebral 
fractures was not sought in any subject in Group C. 
Questionnaire 
Each patient completed a standardized, detailed questionnaire designed to docu- 
ment putative risk factors in the pathogenesis of osteoporosis and the extent and se- 
verity of involvement of osteoporosis. There were 21 categorical (yes/no) responses 
and 8 numerical responses. We attempted to make the interview process as uniform 
as possible by limiting the number of interviewers. Every attempt was made to have 
the subjects restrict their responses to their diet and life-style during most of their 
adult life and avoid reporting recent changes. In a similar vein, all interviewers 
stressed that questions on exercise concerned involvement in a regular exercise 
program and not exercise associated with the activities of daily living. 
Calcium intake was calculated based on a food frequency questionnaire pertain- 
ing to usual weekly intake of milk and cheese (see Table l), which provide approxi- 
mately 60% of dietary calcium in the American diet [lo]. (The remaining 40% is 
distributed among more than 40 different foods.) Each response category was 
graded as to approximate calcium intake by a dietitian and a summary score was 
computed. Smoking status was coded as current, ex and never. Derailed infonua- 
tion about quantity and duration were not available. Alcohol intake and exercise 
were coded into three categories corresponding to frequent, moderate and none. 
A subject was recorded as having a history of medical illness associated with ac- 
celerated bone loss if she reported any of the following: hyperparathymidism, en- 
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dogenous and exogenous hyperthyroidism, endogenous and exogenous hypercorti- 
s&m, nontropical spree, gastrectomy or short-bowel syndrome. 
Anthropomefry 
Height and weight were measured in indoor clothes, without shoes, on all subjects 
interviewed. Those questioned by telephone were asked their height and weight 
and this was verified by review of the medical records, which should be fairly acco- 
rate since the woman had just had a clinic visit. Stature was measured with a Har- 
penden stadiometer [Ill, except at the satellite clinics (Group C), where a conven- 
tional scale was used. Subjects were asked to stand erect, with eyes directed 
straight ahead, and the horizontal plate or bar was lcwered onto the crown of the 
head. An index of body size was derived from weight/height, which is a general 
measure of body bulk for epidemiologicnl studies in Western female populations 
[la 
Bone mass 
Appendicular bone mass was assessed by single photon absorptiometry 1131. Using 
a Norland bone densitometer bone mineral content (BM, g/cm) and bone width 
(BW, cm) were measured in the non-dominant radius at standard proximal and dis- 
tal sites as the mean of four repeat scans, but without correction for possible calibra- 
tion error. Precision (2-4%) and accuracy (~3% error) are acceptable for cross- 
sectional epidemiological studies. Because of problems in locating the distal site ac- 
curately, and because there was no significant difference in BM between the two 
sit.9 in the VFC and VF- groups, only the proximal measurement was obtained in 
the C group. The ratio BM/BW partly corrects for differences in body size and rep- 
resents an estimate of linear mass density. The deviation of BM/BW from m:an 
value at skeletal maturity is an estimate of absolute bone loss, and the deviation 
from the mean for subjects of the same age is an estimate of relative bone loss. Age- 
specific reference values were determined by interpolation from decadespecific 
values determined on normal subjects in Wisconsin. These deviations were ex- 
pressed as z scores by dividing by the age specific standard deviation. 
st&tic!danalysis 
The three groups VF+, VF- and C were compared for differences between base- 
line characteristics. Analysis of variance or the nonparametric Kruskal-Wallis test 
were used to compare continuous variables as appropriate. Categorical variables 
were examined usingx’ tests for I x c contingency tables. If significance (P < 0.05) 
was observed, all pairwise comparisons were examined. The Bonferroni method of 
adjustment for multiple testing was used. 
Multiple stepwise logistic regression (MLR) was used to find sets of variables 
which best predicted vertebral fractures when comparing the VF+ and control 
groups and when comparing the VF+ and VF- groups [14]. A forward stepwise al- 
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gorithm was used. This procedure was implemented on a randomly selected sub- 
population consisting of approximately one half of the available patients. The mod- 
el was then evaluated for possible use as a screening tool by applying it to the re- 
maining half of the subjects. 
The screening characteristics of the models were evaiuatrd usin,o receiver oper- 
ating characteristic (ROC) curves [U]. These plot the sensitivity versus one minus 
the specificity for all reference or cutpoint values possible. The set of cutpoints 
were defined as the probabilities of fracture generated for each patient from the fi- 
nal logistic model. The areas under the curve are computJ and compared between 
various models. The area can be interpreted as the average sensitivity over all pos- 
sible values of the specificity. We had no a priori range of specificities of interest 
and so the entire area under the ROC curve is important. 
A single cutpoint, for each logistic model, was evaluated to determine estimates 
of predictive values. The cutpoint was chosen by minimizing a weighted sum of mis- 
classifications where the weights were the sample size of the classification group 
1161. The minimization procedure was performed on the data used to generate the 
model. Assessment was then made using the confirmatory data set. A single stage 
screening, based on each model generated, was evaluated. A two-stage screen was 
also considered where the questionnaire-based model was used to identify patients 
for further screening with bone densitometry. All predictive values were computed 
assuming a prevalence of vertebral fractures of 5% in the population to be screened 
PI. 
Multiple linear regression techniques were used to generate models predicting 
various bone mineral content measures. A stepwise algorithm was used with the in- 
clusion/exclusion P-value set at 0.05. The entire set of data was used in this analysis. 
Table 1 summarizes the historical and anthropometric data on the three groups of 
women. The women with osteoporosis and vertebral compression fractures (VF+) 
were older than the other two groups and consequently more years had elapsed 
since their menopause. These women were lighter than both controls and VF- 
groups and smaller (weight/height) than the control group. 
Menstrual and menopausal history were similar in the three groups. The VF- 
group had the highest percentage of women with a surgical menopause, the highest 
percentage receiving hormonal therapy and the greatest average duration of thera- 
py. However, none of these results were statistically significant as compared to 
either VF+ or C groups. 
With regard to reproductive history, the VF+ group had slightly fewer children 
than the control group but the prevalence of nulliparity was similar in the three 
groups. Differences in prevalence of lactation and lifetime duration of lactation 
could not be detected. 
A greater percentage of women with osteoporosis and vertebral compression 
fractures (VF+) were current smokers than in the VF- and C groups but the results 
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a Any entry in this column indicates that &I for differences among the 3 groups was si@icant, P < 
0.05. The painvise comparisons, 1, VF+ vs. C, 2, VFC vs. VT- and 3, VF- vs. C, are indicated if 
P<O.O,,. 
were not statistically significant. It is also the case that more women in the VF- 
group exercised than in the other two groups. 
A positive family history of osteoporosis was very common in the subjects evalu- 
ated ia this study. While this history was more prevalent in those groups seeking 
consultation for osteoporosis (VFC, VF-), nearly one-third of women in the con- 
trol group, who had specifically denied ever seeking medical attention for osteopo- 
Table 2 
bone mineral content 0.63 * 0.13 0.73 * 0.13 0.73 * 0.13 1.2 
bone mineral/bone width 0.52 f 0.09 0.59 + 0.09 0.59 i 0.10 1.2 
adjusted bone mineral -l.M)f 1.25 -0.80* 1.12 -1.04 * 1.32 I,2 
absolute bonemineral -4.87 f 1.93 -3.64 f 1.86 -3.66t2.04 1.2 
arts, 
bone mineral content 0.G3 + 0.15 0.73*0.15 2 
bone minerallbone width 0.37 * 0.07 0.43 f O.l@ 2 
adjusted bone mineral -1.82f 1.45 -1.15 * 1.59 2 
absolute bane mineral -Ml5 * 2.15 -3.61 + 2.13 2 
’ Any entry in this column indicatmes that test for differences among the 3 groups was rignificant, P c 
0.05. The paimise comparisons, 1, VF+ vs. C, 2, VFC vs. VF-, and 3, VF- vs. C, are indicated if 
P < 0.017. 
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rosis or its prevention, had a positive family history of osteoporosis. 
Bone mineral content measured by SPA was significantly lower in the VF+ group 
than tbe other two groups. There was no difference in bone mineral content be- 
tween the two control groups (Table 2). 
Since the method of entry into tbe study was different for both groups without 
vertebral fractures (VF- and C) and statistically significant differences could be 
demonstrated between these two groups, subsequent analysis was made comparing 
VP+ to C and VF+ to VF-. No analyses were perforttxd considering VF- and C as 
a single control group. 
Three models were developed using MLR analysis to identify the set of variables 
predicting the presence of vertebral fractures comparing the VF+ to control group. 
The models were based on the questionnaire data, the bone densitometry results 
and the combined data respectively. The models are summarized in Table 3. 
The characteristics of the ROC curves (Fig. lA,B) resulting from tbese models 
were compared by examining the areas under the curves (Table 5). The model 
based on the ratio of bone mineral content to bone width (bone densitometry mod- 
el) had a slightly higher area although the difference was not statistically significant. 
The model based on the combined data was intertoediate in area. 
ROC Curve: 
Vertebral Compression Fractu~re VS. Control 
179 
The optimal cutpoints, defined by minimizing weighted false classifications, re- 
sulted in poor screening characteristics (Table 6). In all cases the sensitivity and 
specificity were low. The positive predictive value, which measures the conditional 
probability of having a vertebral fracture, given that the test indicates this, is only 
slightly elevated beyond the 5% a priori probability.of having a vertebral fractuie.’ 
The analogous conditional probability for not having a vertebral fracture, negative 
predictive value, is also only slightly elevated above the a priori probability of 95%. 
Similar results hold for the comparison of the VF+ to VF- groups (Table 4). The 
model based on the bone densitometry results has a larger area under the ROC 
curve than either the model generated by the questionnaire data or the model gen- 
erated by the combined data (P < 0.01) (Table 5). This is also indicated by the con- 
sideration of the optimal screening parameters. The estimates of both predictive 
probabilities are higher fx the bone densitometry based model (Table 6). 
Again all three modek: have poor screening characteristics. The sensitivities and 
ROC Curve: Vertebral Compression Fracture 
vs. No Vertebral Fracture 
---. E!uenerd~” 
._._. cmDI*d 
. . . WI_ 
Fig. 1. Recciveropcraring characteristic cwve6: (A) vcrwbral compression fracture ~8. control; (El) VW- 
tebral compression fracture vs. no vertebral fracture. Sources: (-----) bone densirometry: (..-......) 
questioionnairc; (-.--.--) combined. 
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Table 3 
L.ogistic regression model: vertebral compression fracture vs. control 
Cocfficienl SD P 
Model. P<O.WI (n = 150) 
bane mineral5one width 
Model, P < O.Wl (n = 146) 
LX... miner&%one width 
weight 



















specificities are low and the screen results in too many misclassified patients to be of 
practical use (Table 6). 
In 1983 the Council on Scientific Affairsof the American Medical Association rec. 
ognized the role of estrogen replacement therapy (ERT) in the prevention of post- 
menopausal osteoporosis. They concluded that “the election of estrogen replace- 
ment for this purpose in the normal menopausal patient can be based only on an as- 
sessment of the relative risks and benefits applicable to the individual patient” [17]. 
However, no information was provided as to how these risks and benefits might be 
assessed. 
In 1984 the NIH consensus Conference on Osteoporosis reached a similar con- 
clusion about the benefit of estrogen in preventing osteoporosis [18]. This coafer- 
ence concluded that osteoporosis is more common in underweight women, that cig- 
arette smoking may be a predictor, and that calcium deficiency has been implicated 
in the pathogen&s of osteoporosis. The possible role of exercise, heredity and 
other dietxy factors (alcohol, vitamin A and C, magnesium and protein) were rec- 
ognized by this conference as being “less firmly established.” At the follow-up Re- 
search Development conference on osteoporosis sponsored by the NIH in 1987, the 
Table 4 
Logistic regression model: vertebral compression fracture VS. no vertebral coa- 
Model, P< o.Wt (n = 23O) 



































Model: VF+ vs. C VF-WC 
-__ 
” ROC n RQC 
SO”rce C VF+ area SE VF- VF+ area SE 
Quest 28 80 0.55 0.070 88 lo6 0.51 0.042 
BD 28 80 0.62 0x64 88 106 0.72 0.037 
BD+ Quest 28 80 0.61 0.065 88 lo6 0.54 0.041 
ROC, receiver operating characteristic% Quest, questionnaire: BD, bone densitomstry; VF+, verte- 
brat compression fracture; VF-, no vertebral compression fracture: C, contml. 
L Patients used to compute these statistics were not included in the 8et wd to idend$ the model. 
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Table 6 
Screening characteristics for optimal screen 
Modrl RZ”S IIEC P+ P- 
VF+ vs. C (n = 80. I, = 28) 
bonedenrilomeky 54 k 5.6 
(43.65) 
quesdonnaire 56 * 5.5 
(45.67) 
banedensdrqucs 64 t 7.4 
(53.75) 
two-stage 36 + 5.4 
(25,411 
V-F+ <x6. VF-(n = 106, n = 88) 
bone densitOmefry 48 f 4.9 
(38.58) 
quesdonnaire 63 k 4.7 
(54.72) 
bone dens & ques 44 f 4.8 
(35.53) 




54 + 9.4 
(36 72) 
57 f 9.4 
(39.75) 
79 f 7.7 
(64.94) 
78 + 4.4 
(69.87) 
39 k 5.2 
(29.49) 






6.0 * 1.3 
(3.18.5) 
7.3 f 1.6 
(4.2.10.3) 
8.3 * 3.0 
(2.4,14.2) 
10.3 * 2.1 
(6.2,14.4) 
5.2 + 0.6 
(4.1,fi.Z) 
5.2 f 0.8 
(3.6.6.8) 
8.6 * 2.1 
(4.4.12.7, 
96.2 f 0.7 
(94.8.97.6) 
9s 9 * 0.8 
(94.2.97.6) 
96.8 i P.7 
(95.4,SS.l) 
95.9 + 0.5 
(94.9.96.9) 
96.6 f 0.4 
(95.9,97.3) 
95.2 * 0.8 
(93.6.96.9) 
9.5.2 f 0.6 
(94.0.96.3) 
95.8 f 0.3 
(95.2.%.5) 
sens, sensirivity: spec, specificity; PC, positive predicdve value; P-, negative predictive value. Mean t 
SE with 95X+ mnfidence interval reported. 
results of which were recently reported [19], stated little progress had been made in 
identifying historical risk factors for the development of PMO. In particular the risk 
attributed to alcohol, smoking and low dietary calcium was considered not weil es- 
tablished. 
We were unable to confirm that several putative diet and life style characteristics 
help predict who will or will not develop PM0 with vertebral fractures. A low diet- 
ary calcium intake during childhood and adolescence results in a lower peak adult 
bone mass and an increased prevalence of osteoporotic fractures [20] but the role of 
dietary calcium once peak adult bone mats has been established has recently been 
questioned [21]. Furthermore, the prevalence of a low dietary calcium intake in 
peri- and postmenopausal women in the United States is so high [22] that it is not 
surprising that the discriminant value of this characteristic is low. 
Our control group was recruited from general medical clinics where the incidence 
of tobacco- and alcohol-related illnesses may be high and this group may not be rep- 
resentative of the use of these substances in the general community. However, the 
prevalence of both tobacco and alcohol use in our control population is very similar 
to that reported by the National Center for Health Statistics for 1987 [23], the most 
recent year for which such information is available. We are unaware of any similar 
data with respect to participation in regular exercise, which is difficult to quantitate. 
The VF- and VF+ groups are not representative of the general population. 
These groups together, however, are representative of those most like:y to be 
183 
screened for possible high risk of osteoporosis. 
Both the AMA and NIH reports recognized that osteoporosis is less frequent in 
blacks and in obese women and more frequent in women with a premature meno- 
pause. Several medical and surgica! conditions (e.g., hyperparathyroidiim, en- 
dogenous and exogenous hyperthywidism, endogenous and exogenous hypercorti- 
solism, nontropical sprue, gastrectomy and short-bowel syndrome) are known to be 
independently associated with metabolic bone disease, including osteoporosis. Wo- 
men who, at the time of their menopause, provide a past OI carrent history of one or 
more of these conditions should also be regarded as being at increased risk for the 
development of PM0 with vertebral fractures. 
If one excluded from an osteoporosis screening program black or obese women 
(because their risk is low) or women with premature menopause or one of the above 
mentioned medical or surgical conditions (because their risk is high) one is still left 
with the vast majority of white (and possibly Asian) women who enter the meno- 
pause between age 45 and 55 years enjoying good health. As long as the prevailing 
medical practice is to restrict estrogen prophylaxis against osteoporosis to those 
otherwise healthy women felt to be at risk of its development, it is imperative to es- 
tablish some mechanism for assessing that risk. 
Spinal radiographs were oat obtained in our control population raising the possi- 
bility of misclassification. However, the correct classification of the VF- group was 
verified by X-ray making it unlikely that potential misclassification of the control 
group influenced the negative results of this study since the VF+ versus C and VP+ 
verstts VF- results wete similar. 
Ideally, determination of risk should be based on prospective studies performed 
‘on a randomly selected group of white women. Retrospective cross-sectional stud- 
ies, such as the one we report here, do represent a compromise and their interpreta- 
lion is subject to the many limitations of Such studies. Nonetheless, it is apparent 
Table 7 
Comparison of areas under ROC curve 
Present study SPA (Iorearms (control)) 63 * 6 
SPA (forearms (VF-)) 71 *4 
Ref. 27 SPA (forearm) 65 * P 
DPA (spine) 78 * 2. 
Ref. 28 SPA 73 * 1 
DPA 71*: 
QCT 77 t 4 
TBC 78 * 4 
Ref. 29 SPA 84 * 2 
DPA 86 t 3 
TRC 90+2 
-__ 
SPA, single photon abrorptiometry; DPA. dual photon absorptiomctry; QCT, quantitative computed 
lomogrrphy; TBC, total body calcium by neutron activation. 
’ We sstbnated standard errors bared on data Siven in paper. 
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from cur data that, while differences can be demonstrated between the groups of 
women we studied by both uni- and multiple variate analysis, these differences are 
small and of questionable biological significance. Thay also lack the necessary sen- 
sitivity and specificity to answer the clinical question we have addressed, i.e., can 
one identify the woman most likely to develop a fracture and therefore to derive 
benefit from ERT for prophylaxis against PMO? 
Our study can be criticized for the crude nature of the instruments we have used. 
However, clinical history, simple antbropometry and measurement of radial bone 
mineral density (BMD) by single photon absorptiometry remain the cheapest, most 
convenient and widely wailable methods and therefore are most suited to a corn- 
munity-wide screening program. Furthermore, despite the availability of more rig- 
orous methods, dietary histories and SPA provide reasonably good measurements. 
For example, in a review of dietary assessment methods, Block concludes that diet 
histories reflect “some reasonably stable marker which is similarly revealed by dif- 
ferent methods . and which bears scime relationship to clinical criteria” [24]. 
Even when dietary calcium intake has changed, as is often the case in postmeno- 
pausal women [25], dietary histories are fairly reliable [26]. The bone density re- 
sults obtained by SPA, as seen in Table 7 are similar to those reported for the more 
expensive and time-consuming methods of dual photon absorptiometry, quantita- 
tive computed tomography and total body calcium by ncctron activation analysis 
[27-29]. 
Table 8 
Predictive models for bone mineral content 
--__ 








Model. P< 0.001. R = 0.61. R’= 0.37, n = 417 






















’ Nullip.wify(l = no.2 = yes): hirtoryofif~nens(l = no.2 = yes). 
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The putative historical risk factors and anthropometry are more likely to be de- 
terminants of bone mass rather than independent determinants OL the risk of SW- 
taining an osteoporotic vertebral fracture and this is borne out by the ROC ctxws 
we have generated. In fact, 37% of the variance in bone mass can be accounted for 
by components of the questionnaire (Table 8). When age is removed fmm this con- 
sideration, only 12% of the variance of the age-adjusted z score for bone mass can 
be accounted for by components of the questionnaire (Table 8). A major determi- 
nant of bone mass not directly addressed by our study is that attributable to genetic 
factors (e.g., parental maternal bone mass). Our data strongly support the argu- 
ment that an assessment of risk of developing PM0 with vertebral fractures cannot 
be made without sottte measwement of bone mass. This is particularly evident from 
Tables 1 and 2 which demonstrate diierences in the historical and anthropometric 
data in the two control groups (VF- and C) but no difference whatever in their COT- 
tical bone mass. 
This retrospective analysis also cannot, in the strictest sense, permit an assess- 
ment of the risk of developing PM0 with vertebral fractures. More correctly, it is 
an assessment of the sensitivity and specificity of the methods with respect to the 
diagnosis of such fractures - a diagnosis that should only be established by spine 
radiographs. Nonetheless, it seetns logical to conclude that the limited differences 
documented between these well defined groups are likely to be even more limited 
in the healthy, younger perimenopausal population without fractures. 
This work was supported by grant #2 ROl AM 28583 from the NIH. 
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